Fifth Third Bancorp Axogen, Inc. Transaction History

Fifth Third Bancorp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $7,012 - $11,866	-580 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$18.5 - $25.47 $10,730 - $14,772	580 New	580 $11,000
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $80,520 - $132,825	-3,300 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	3,300	3,300 $55,000

179

36.2M

82.6K

1.1K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.